ANCA-associated vasculitides | Medibuddy
18th February 2025

ANCA-associated vasculitides

It may be helpful to group some of the below conditions as investigation and management are similar. The primary ANCA-associated vasculitides are GPA, MPA, EGPA and IPIPC. Treatment, where there is life-/organ-threatening disease, is usually IV methylprednisolone and cyclophosphamide/rituximab.

Upper airway and ENT features Asthma Nodules, cavities and infiltrates Alveolar haemorrhage c-ANCA positivity (%) p-ANCA positivity (%)
GPA Very common Rare Very common 5-10% 70 25
MPA Rare Rare Uncommon 10-30% 25 60
EGPA Very common Very common Very common Rare < 5 35
Anti-GBM Rare Rare Very common 25-60% 5 25

Table 5 Typical pulmonary manifestations of several small-vessel vasculitides

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.